Physician profile
John Flannery
NPI 1316996614
$4,231.49
in general payments reported to CMS, 2019-2025
18 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $140 · 2021: $27.20 · 2022: $2,865 · 2023: $493 · 2024: $176 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,801.28 | 2022 | |
| Blueprint Medicines Corporation | $299.54 | 2023-2025 | Ayvakit |
| Emd Serono, INC. | $264.20 | 2023-2024 | Bavencio |
| Medtronic, INC. | $249.19 | 2021-2025 | Eea, Signia |
| Dova Pharmaceuticals | $216.06 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $65.05 | 2019 | |
| Abbvie INC. | $59.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.22 | 2019-2020 | |
| Braintree Laboratories, INC. | $38.33 | 2019-2022 | |
| Shire North American Group INC | $24.82 | 2019 | |
| Ethicon US, LLC | $23.56 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.23 | 2023 | Exparel |
| Daiichi Sankyo INC. | $21.21 | 2020 | |
| Adc Therapeutics America, INC. | $20.57 | 2022 | |
| Tactile Systems Technology INC | $17.40 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $17.19 | 2019 | |
| Merck Sharp & Dohme LLC | $16.41 | 2019 | |
| Ucb, INC. | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Flannery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.